News & Press Releases
Filter by:
Of Counsel Benjamin Zegarelli was quoted in 360Dx related to the future of oversight for laboratory-developed-test following a recent decision in the Eastern District of Texas that vacated the FDA's final rule on LDTs.
Drug Cartels as Foreign Terrorists: AML Spotlight
April 1, 2025
Member Steve Ganis was quoted in a FinOps Report article about how President Trump’s decision to classify drug cartels as foreign terrorist organizations (FTOs) has alerted anti-money laundering compliance executives at US financial institutions doing business in Latin America, particularly over AML compliance.
Dr. Fear Factor: How 401k Fiduciaries Can Teach Participants to Stop Worrying and Love Volatility
April 1, 2025
Of Counsel Michelle Capezza was quoted in a Fiduciary News article discussing the important role education plays for retirement plan participants and the challenges employers face in providing such education.
The State of Pay Transparency
April 1, 2025
Member Natalie Groot and Associates Talia Weseley and Danielle Dillon wrote an article exploring the state of pay transparency laws published by the Employee Relations Law Journal. In the article, the authors look at trends surrounding pay transparency laws and discuss the responsibilities they place on employers.
The Employee Relations Law Journal published an article by Member Geri Haight and Associate Tom Pagliarini about the implications of President Trump’s decision to remove officials at the Equal Employment Opportunity Commission and the National Labor Relations Board.
Member Lauren Moldawer recently connected with AIS Health about a Florida pharmacy benefit manager (PBM) law, the Prescription Drug Reform Act (PDRA). The Act aims to lower drug costs by requiring PBMs to forward all manufacturer rebates to plan sponsors and prohibiting mandatory mail-order pharmacy use for enrollees, among other reforms.
